Most focus on STAT3 signalling is centred on pY705STAT3, the transcription-promoting form of the protein [54–56], which drives many adverse cancer features such as epithelial-mesenchymal transition in HER2-positive breast tumours [57]. This evidence concerns the gene STAT3 and breast neoplasm.